The new Massachusetts Life Sciences Center is still working on how it will distribute $500 million of state money. On the table: Evaluating the commercial and scientific value of a new technology, how to split the moneyt between biotech, pharma and medical devices and how much should be earmarked for small companies vs. large ones. Report [1]
Links:
[1] http://www.wbjournal.com/news41595.html